Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands

Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands

Here, we describe the case of a 74-year-old male patient with a high-risk prostate carcinoma who underwent positron-emission tomography/computed tomography (PET/CT) with [<sup>68</sup>Ga]Ga-prostate-specific membrane antigen ([<sup>68</sup>Ga]Ga-PSMA-11) for staging. [<sup...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cesare Michele Iacovitti, Barbara Muoio, Marco Cuzzocrea, Gaetano Paone, Giorgio Treglia
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Diagnostics
Subjects:	PET positron-emission tomography nuclear medicine hybrid imaging PSMA gastric cancer
Online Access:	https://www.mdpi.com/2075-4418/15/1/101
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating [<sup>68</sup>Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study
by: Andrea Di Giorgio, et al.
Published: (2024-12-01)

Incidental discovery of gastrointestinal stromal tumor via PSMA-PET/CT imaging: Insights from a case report
by: Venetia A. Florou, et al.
Published: (2025-01-01)

Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study
by: Le Ma, et al.
Published: (2025-01-01)

Imply on diagnosis and early prognosis of preoperative [68Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin
by: K. Pełka, et al.
Published: (2025-01-01)

Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT: a comparison to MRI using histopathology as reference
by: Erland Hvittfeldt, et al.
Published: (2025-01-01)

Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
by: Ilham Badrane, et al.
Published: (2024-12-01)

Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer
by: Marco M. E. Vogel, et al.
Published: (2025-01-01)

The impact of preliminary patient hydration on physiological [18F]PSMA-1007 uptake in the urinary bladder on PET/CT
by: T. L. Antonevskaya, et al.
Published: (2024-06-01)

Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
by: Pete Tually, et al.
Published: (2024-12-01)

Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
by: Ana Rodríguez-Pajuelo, et al.
Published: (2025-02-01)

B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases
by: Theresa Jung, et al.
Published: (2025-01-01)

Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study
by: Junjie Fan, et al.
Published: (2025-02-01)

18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study
by: Jisce R. Puik, et al.
Published: (2025-01-01)

Diagnostic accuracy of 18F Prostate Specific Membrane Antigen (PSMA) PET-CT radiotracers in staging and restaging of high-risk prostate cancer patients and patients with biochemical recurrence: protocol for an overview of reviews [version 2; peer review: 2 approved]
by: Susan Ahern, et al.
Published: (2025-01-01)

Fully Automated Production of (((<i>S</i>)-1-Carboxy-5-(6-([<sup>18</sup>F]fluoro)-2-methoxynicotinamido)pentyl)carbamoyl)-<span style="font-variant: small-caps">l</span>-glutamic Acid ([<sup>18</sup>F]JK-PSMA-7)
by: Philipp Krapf, et al.
Published: (2025-01-01)

Staging of esophageal cancer using PET/MRI: a systematic review with head-to-head comparison
by: Alisa Mohebbi, et al.
Published: (2025-01-01)

[18F]FDG PET-Based Radiomics and Machine Learning for the Assessment of Gliomas and Glioblastomas: A Systematic Review
by: Francesco Dondi, et al.
Published: (2025-01-01)

Investigating the significance of SPECT/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review
by: Tahani O. Alkahtani
Published: (2025-01-01)

Diffused Multi-scale Generative Adversarial Network for low-dose PET images reconstruction
by: Xiang Yu, et al.
Published: (2025-02-01)

Feasibility study of PET/CT for the detection and localization of nervous system damage caused by trimethyltin chloride
by: Anqing Liu, et al.
Published: (2025-01-01)

PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny
by: Mohammad A. Alzubi, et al.
Published: (2025-02-01)

PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature
by: Anusha Agarwal, et al.
Published: (2025-01-01)

Research on the characteristics of 18F-FDG PET/CT in mantle cell lymphoma and the discrimination between cellular morphological variants
by: REN Yixuan, et al.
Published: (2024-12-01)

Radioterapia guiada por PET-PSMA en cáncer de próstata: experiencia en el escenario curativo y en el salvamento
by: Juan C. Galvis, et al.
Published: (2023-04-01)

Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment
by: Lauren Hekman, et al.
Published: (2023-01-01)

Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system
by: Xueqian Yang, et al.
Published: (2024-12-01)

Alphaherpesvirus in Pets and Livestock
by: Shu-Hui Duan, et al.
Published: (2025-01-01)

Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET/CT
by: Secerov-Ermenc Ajra, et al.
Published: (2024-10-01)

An Analysis of Age-Related Body Composition Changes and Metabolic Patterns in Korean Adults Using FDG-PET/CT Health Screening Data
by: Chang-Myung Oh, et al.
Published: (2025-01-01)

18F-FDG PET/CT findings of erythema induratum
by: KyungAh Chun, MD, PhD
Published: (2025-04-01)

A Study on the Attachment to Pets Among Owners of Cats and Dogs Using the Lexington Attachment to Pets Scale (LAPS) in the Basque Country
by: Eider Egaña-Marcos, et al.
Published: (2025-01-01)

Editorial: Nuclear medicine advances through artificial intelligence and intelligent informatics
by: Lisa M. Duff, et al.
Published: (2025-01-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
by: Yong-Jin Park, et al.
Published: (2025-01-01)

PET in neurotherapeutic discovery and development
by: Melissa Chassé, et al.
Published: (2025-01-01)

Case report: Detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET/CT
by: Simon M. Petzinna, et al.
Published: (2024-12-01)

Role of Computed Tomography in Predicting Programmed Death Ligand-1 Positivity in Gastric Adenocarcinoma
by: Yu ZH, et al.
Published: (2025-02-01)

Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy
by: Jan Heilinger, et al.
Published: (2025-01-01)

Whole-body PET/MRI to detect bone metastases: comparison of the diagnostic performance of the sequences
by: Ulusoy Onur Levent, et al.
Published: (2024-11-01)

Analysis and forecasting of pet food markets using extrapolation methods
by: O. Nikolaieva, et al.
Published: (2024-06-01)

PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis
by: Patrícia Marques-Alves, et al.
Published: (2025-01-01)